Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23772375 | 0.87 | CA12 (0.35) | KMT2AHPGDALDH1A1MEN1MAPT | |
| SCHEMBL24012248 | 0.83 | ANPEP (0.31) | — | |
| SCHEMBL17448853 | 0.80 | ANPEP (0.46) | KMT2AALDH1A1MEN1MAPTLMNA | |
| SCHEMBL24012157 | 0.78 | KMT2A (0.36) | KMT2AHPGDALDH1A1MEN1MAPT | |
| SCHEMBL24011834 | 0.78 | LMNA (0.31) | KMT2AALDH1A1MEN1MAPTLMNA | |
| SCHEMBL25868505 | 0.78 | ANPEP (0.43) | ALDH1A1MAPTLMNA | |
| SCHEMBL24012156 | 0.78 | MMP9 (0.33) | KMT2AALDH1A1MEN1MAPTKDM4E | |
| SCHEMBL24012192 | 0.77 | NTRK1 (0.34) | KMT2AALDH1A1MEN1MAPTLMNA | |
| SCHEMBL24011892 | 0.77 | — | — | |
| SCHEMBL24011958 | 0.77 | NR1H3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | Konica Minolta, Inc. (JP) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210351356-A1 | IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES | IGF1R, IK, BMI1 | KMT2A 1999/4885HPGD 3687/4885ALDH1A1 1227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.